Health Advance Submits Multiple Filings to SEC in Efforts to Bring the Company Current Following Change in Management
December 28 2017 - 3:28PM
COLORADO SPRINGS, Colo., Dec. 28, 2017 (GLOBE
NEWSWIRE) -- Recently Health Advance Inc. (OTC PINK:HADV)
submitted multiple filings to EDGAR bringing the Company current on
federal filing requirements and satisfying requests made by the SEC
in August. The filings include disclosure about the exit of the
former President of the Company, recent legal action, change of
fiscal year-end and the quarterly report for September 30, 2017,
and changes in control and management.
Thus, the multiple filings of Form 8-K
amendments and the 10-Q quarterly report bring the Company current
on all filing requirements and will allow the company to proceed
forward into its new fiscal year-end of March 31, 2018.
Micro Medtech Ltd. remains active with the
Company under a license agreement, working on developing two
patented medical food formulations derived from NSAID alternatives
and botanical extract blends that contain kava, cannabidiol
("CBD”), and mitragyna speciosa (better known as kratom)-
Med-patents, known as Polyoxyfen and
Cebidiofen.
For more information about Health Advance visit
www.hadvinc.com and www.staycleanmed.com.
Media Relations Contact:
media@hadvinc.com
Phone: 719-466-6699
Health Advance (PK) (USOTC:HADV)
Historical Stock Chart
From Sep 2024 to Oct 2024
Health Advance (PK) (USOTC:HADV)
Historical Stock Chart
From Oct 2023 to Oct 2024